Unique ID issued by UMIN | UMIN000044496 |
---|---|
Receipt number | R000050837 |
Scientific Title | Effect of intake of the DHA containing food on cognitive function and prevention of long-term frailty |
Date of disclosure of the study information | 2021/06/12 |
Last modified on | 2022/10/13 18:07:54 |
Effect of intake of the DHA containing food on cognitive function and prevention of long-term frailty
Effect of intake of the DHA containing food on cognitive function and prevention of long-term frailty
Effect of intake of the DHA containing food on cognitive function and prevention of long-term frailty
Effect of intake of the DHA containing food on cognitive function and prevention of long-term frailty
Japan |
Healthy elderly subjects
Adult |
Others
NO
To estimate the effect of the DHA containing food on cognitive function and prevention of long-term frailty
Efficacy
Exploratory
MMSE, MoCA, Plasma BDNF concentration, Plasma NGF concentration, Plasma omega 3-fatty acids concentration (DHA and EPA), Plasma DHA concentration, Plasma EPA concentration, CRP concentration, Lean body mass, BMI, SMI, Subjective health status, Frequency of going out
Interventional
Parallel
Randomized
Individual
Single blind -investigator(s) and assessor(s) are blinded
Placebo
2
Prevention
Food |
24 weeks ingestion of active food
24 weeks ingestion of placebo food
65 | years-old | <= |
85 | years-old | >= |
Male and Female
1) Subjects giving written informed consent
2) Participants in the project for prevention of long-term frailty in Obihiro City, Hokkaido
3) Subjects aged 65 to 85 years old when consent acquisition
4) Subjects whose MMSE score is 22 points or more
1) Subjects who have diagnosed with dementia, malignant tumor, chronic renal failure or diabetes
2) Subjects who have significant abnormal blood test score
3) Subjects who are prescribed antipsychotics, dementia treatment drugs, ethyl icosapentaebiate or omega 3-fatty acid ethyl
4) Subjects taking supplements that are expected to improve brain function more than 4 days a week
5) Subjects taking supplements containing EPA and/or DHA more than 4 days a week
6) Subjects who are prescribed anticoagulants and antiplatelet drugs.
7) Subjects who have milk allergy or lactose intolerance
8) Subjects who have soy allergy
9) Subjects who participate in other clinical trials within the past month or have plans to participate in other clinical trials during this study period
10)Subjects who determine ineligible by the principal investigator or sub-investigator
100
1st name | Nakamura |
Middle name | |
Last name | Kentaro |
Meiji Co., Ltd.
R&D Division
192-0919
1-29-1 Nanakuni, Hachiouji, Tokyo, Japan
+81-42-632-5846
kentarou.nakamura@meiji.com
1st name | Yoshimura |
Middle name | |
Last name | Aya |
Meiji Co., Ltd.
R&D Division
192-0919
1-29-1 Nanakuni, Hachiouji, Tokyo, Japan
+81-42-632-5846
aya.yoshimura.aa@meiji.com
Meiji Co., Ltd.
Meiji Co., Ltd.
Profit organization
Meiji Institutional Review Board
1-29-1 Nanakuni, Hachiouji, Tokyo
+81-42-632-5900
MEIJI.IRB@meiji.com
NO
2021 | Year | 06 | Month | 12 | Day |
Unpublished
77
Completed
2020 | Year | 04 | Month | 22 | Day |
2020 | Year | 04 | Month | 22 | Day |
2021 | Year | 08 | Month | 18 | Day |
2022 | Year | 03 | Month | 18 | Day |
2021 | Year | 06 | Month | 10 | Day |
2022 | Year | 10 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050837
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |